Barbara Gayle Duncan - Jun 14, 2022 Form 4 Insider Report for Fusion Pharmaceuticals Inc. (FUSN)

Role
Director
Signature
/s/Maria Stahl as Attorney-in-Fact for Barbara Duncan
Stock symbol
FUSN
Transactions as of
Jun 14, 2022
Transactions value $
$0
Form type
4
Date filed
6/22/2022, 07:07 PM
Previous filing
Apr 12, 2022
Next filing
Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Opion (Right to Buy) Award $0 +17K $0.00 17K Jun 14, 2022 Common Stock 17K $3.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option fully vests on the earlier of (i) June 14, 2023 or (ii) the 2023 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.